The IPO, which was arranged by Investec, raised approximately £93 million for the company and the selling shareholders, including Lloyds Development Capital. Dealings in the shares, which have been priced at 134 pence, are expected to commence on AIM on 7 November 2014.
The Osborne Clarke team, which was led by corporate finance Partners Jonathan King and Mark Wesker, comprised Senior Associate Samantha Myers, Associate James Davies and Trainee Tom McGinn.
Commenting on the IPO, Osborne Clarke Head of Equity Capital Markets, Jonathan King said:
“Fever Tree is a great brand with a fantastic story, echoed by the strong interest shown from new investors despite extremely challenging market conditions. We look forward to sharing a well-deserved G&T with management shortly!”